source
- Acceleron veterans and Westlake back new IPF biotech Oorja Bio with $30 million Series AEntrepreneurs who previously brought the drug Winrevair to market have launched a new biotech, Oorja Bio, to target idiopathic pulmonary fibrosis, a hard-to-treat lung disease. The company announc…
- Former FDA commissioner sees hope for stability under new acting leader Kyle DiamantasAt a recent STAT Breakthrough Summit West, former FDA commissioner David Kessler addressed concerns about the agency’s recent turmoil and staff departures. Kessler said the appointment of acting c…